S&P 500 Futures
(0.01%) 5 207.25 points
Dow Jones Futures
(0.08%) 39 030 points
Nasdaq Futures
(-0.08%) 18 181 points
Oil
(-0.05%) $78.44
Gas
(-1.55%) $2.16
Gold
(-0.17%) $2 327.30
Silver
(-0.57%) $27.46
Platinum
(0.21%) $966.90
USD/EUR
(0.08%) $0.929
USD/NOK
(0.29%) $10.86
USD/GBP
(0.21%) $0.798
USD/RUB
(-0.57%) $90.83

リアルタイムの更新: Abbott Laboratories [ABT]

取引所: NYSE セクター: Healthcare 産業: Medical - Devices
最終更新日時7 5月 2024 @ 05:00

-0.25% $ 105.64

Live Chart Being Loaded With Signals

Commentary (7 5月 2024 @ 05:00):

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices...

Stats
本日の出来高 3.75M
平均出来高 5.65M
時価総額 183.77B
EPS $0 ( 2024-04-17 )
次の収益日 ( $1.100 ) 2024-07-18
Last Dividend $0.550 ( 2024-04-12 )
Next Dividend $0 ( N/A )
P/E 32.91
ATR14 $0.0400 (0.04%)
Insider Trading
Date Person Action Amount type
2024-04-26 Stratton John G Buy 1 866 Common shares without par value
2024-04-26 Starks Daniel J Buy 1 866 Common shares without par value
2024-04-26 Starks Daniel J Buy 5 277 Option (right to buy)
2024-04-26 Roman Michael F Buy 1 866 Common shares without par value
2024-04-26 O'grady Michael Buy 4 404 Option (right to buy)
INSIDER POWER
55.33
Last 99 transactions
Buy: 1 141 010 | Sell: 385 716

ボリューム 相関

長: 0.05 (neutral)
短: 0.62 (weak)
Signal:(69.429) Neutral

Abbott Laboratories 相関

10 最も正の相関
ULE0.948
FXE0.947
UDN0.941
EWN0.937
BWX0.936
DRI0.935
NERD0.934
LEMB0.932
EMLC0.932
BYM0.931
10 最も負の相関
EUO-0.946
UUP-0.923
TNK-0.916
USDU-0.909
DEX-0.902
TYO-0.893
PST-0.892
TBX-0.886
TMV-0.883
MIE-0.883

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Abbott Laboratories 相関 - 通貨/商品

The country flag -0.84
( strong negative )
The country flag -0.86
( strong negative )
The country flag 0.00
( neutral )
The country flag -0.50
( weak negative )
The country flag -0.64
( weak negative )

Abbott Laboratories 財務諸表

Annual 2023
収益: $40.11B
総利益: $22.13B (55.18 %)
EPS: $3.30
FY 2023
収益: $40.11B
総利益: $22.13B (55.18 %)
EPS: $3.30
FY 2022
収益: $43.65B
総利益: $24.51B (56.15 %)
EPS: $3.94
FY 2021
収益: $43.08B
総利益: $24.54B (56.97 %)
EPS: $3.99

Financial Reports:

No articles found.

Abbott Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.470
(N/A)
$0.470
(N/A)
$0.510
(N/A)
$0.510
(N/A)
$0.510
(N/A)
$0.510
(N/A)
$0.550
(N/A)
$0.550
(N/A)
$0
(N/A)
$0
(N/A)

Abbott Laboratories Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.85 - Stable (17.06%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.00589 1983-01-11
Last Dividend $0.550 2024-04-12
Next Dividend $0 N/A
Payout Date 2024-05-15
Next Payout Date N/A
# dividends 166 --
Total Paid Out $25.20 --
Avg. Dividend % Per Year 1.43% --
Score 5.88 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.85
Div. Directional Score 9.38 --
Next Divdend (Est)
(2024-07-02)
$0.557 Estimate 74.91 %
Dividend Stability
1.00 Excellent
Dividend Score
5.88
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1983 $0.0269 2.59%
1984 $0.0323 2.50%
1985 $0.0379 3.32%
1986 $0.0452 2.37%
1987 $0.0398 1.49%
1988 $0.0644 2.36%
1989 $0.0756 2.82%
1990 $0.0904 2.32%
1991 $0.108 2.22%
1992 $0.129 1.71%
1993 $0.148 2.17%
1994 $0.166 2.57%
1995 $0.184 2.50%
1996 $0.209 2.23%
1997 $0.296 2.62%
1998 $0.263 1.73%
1999 $0.296 1.35%
2000 $0.332 2.11%
2001 $0.368 1.70%
2002 $0.409 1.63%
2003 $0.435 2.42%
2004 $0.477 2.27%
2005 $0.521 2.33%
2006 $0.558 2.94%
2007 $0.610 2.60%
2008 $0.675 2.52%
2009 $0.749 2.91%
2010 $0.825 3.16%
2011 $0.901 3.93%
2012 $0.965 3.55%
2013 $0.560 1.75%
2014 $0.880 2.30%
2015 $0.960 2.14%
2016 $1.040 2.42%
2017 $1.060 2.71%
2018 $1.120 1.91%
2019 $1.280 1.84%
2020 $1.440 1.66%
2021 $1.800 1.65%
2022 $1.880 1.35%
2023 $2.04 1.86%
2024 $1.100 1.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
ORC Dividend Royal 2023-11-29 Monthly 12 9.23% 8.50
SRV Dividend Royal 2023-12-04 Monthly 18 7.53% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1401.5007.2110.00[0 - 0.5]
returnOnAssetsTTM0.07771.2007.418.89[0 - 0.3]
returnOnEquityTTM0.1481.5009.4710.00[0.1 - 1]
payoutRatioTTM0.644-1.0003.56-3.56[0 - 1]
currentRatioTTM1.5960.8007.025.62[1 - 3]
quickRatioTTM0.9450.8009.147.32[0.8 - 2.5]
cashRatioTTM0.4481.5008.6210.00[0.2 - 2]
debtRatioTTM0.201-1.5006.65-9.97[0 - 0.6]
interestCoverageTTM10.861.0007.097.09[3 - 30]
operatingCashFlowPerShareTTM4.122.008.6310.00[0 - 30]
freeCashFlowPerShareTTM2.842.008.5810.00[0 - 20]
debtEquityRatioTTM0.376-1.5008.50-10.00[0 - 2.5]
grossProfitMarginTTM0.5411.0004.314.31[0.2 - 0.8]
operatingProfitMarginTTM0.1671.0008.658.65[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4901.0008.398.39[0.2 - 2]
assetTurnoverTTM0.5560.8009.627.70[0.5 - 2]
Total Score12.90

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM32.541.0006.810[1 - 100]
returnOnEquityTTM0.1482.509.6610.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.842.009.0510.00[0 - 30]
dividendYielPercentageTTM2.011.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM4.122.008.6310.00[0 - 30]
payoutRatioTTM0.6441.5003.56-3.56[0 - 1]
pegRatioTTM0.3301.500-1.1350[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1771.0008.070[0.1 - 0.5]
Total Score5.85

Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。